Close

GBT Financial Facts

Earnings per share - diluted: 0.12
Earnings per share - basic: 0.13
See Full Income Statement

Accounts payable: 3.18M
Other assets: 85.96K
See Full Balance Sheet

Global Blood Therapeutics (GBT) Earnings

  |   Expand Research on GBT
Next EPS Date 2/23/23 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -1.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -6.7% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/26/20 Q419 -$1.59-$1.24 -$0.35N/A$560K N/A Details
2/23/22 Q421 -$1.36-$1.13 -$0.23$56.1M$55.44M N/A Details
5/4/22 Q122 -$1.26-$1.30 +$0.04$55.16M$56.14M N/A Details
8/8/22 Q222 -$1.12-$1.18 +$0.06$47.56M$64.39M N/A Details
8/3/21 Q221 -$1.12-$1.19 +$0.07$47.6M$43.84M N/A Details
8/8/22 Q222 -$1.12-$1.18 +$0.06$47.56M$64.39M N/A Details
2/24/21 Q420 -$1.00-$0.94 -$0.06$41.3M$39.03M N/A Details
11/5/20 Q320 -$0.97-$0.73 -$0.24$36.89M$43.98M N/A Details